Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Placebo-controlled, Double-blind Study to Evaluate 2LPAPI® Efficacy on the Clearance of Genital HR-HPV Infections.

NCT04232917 is registered in ClinicalTrials.gov with Labo'Life as lead sponsor.

NCT NCT04232917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04232917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Placebo-controlled, Double-blind Study to Evaluate 2LPAPI® Efficacy on the Clearance of Genital HR-HPV Infections.
Lead sponsor
Labo'Life
Phase
Phase 4
Overall status
Recruiting
Start date
October 17, 2020
Completion date
March 30, 2028
Enrollment
284 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

human papilloma virus